期刊文献+

小儿噬血细胞性淋巴组织细胞增生症42例临床分析 被引量:2

A Clinical Analysis of 42 Children with Hemophagocytic Lymphohistiocytosis
下载PDF
导出
摘要 目的探讨小儿噬血细胞性淋巴组织细胞增生症(Hemophagocytic lymphohistiocytosis,HLH)的病因、临床特点、诊断、治疗及预后情况。方法回顾分析42例小儿HLH的临床资料。结果 42例中男26例,女16例,临床症状以持续高热、肝脾肿大为突出表现,同时部分患儿合并呼吸系统、中枢神经系统、循环系统、泌尿系统等其它脏器受累;42例中感染相关性26例;非感染相关性5例;剩下11例病因不明;根据HLH-94或HLH-2004方案治疗后,好转或治愈19例,死亡13例,失访10例。采用流式细胞术检测了25例患儿外周血CD3+/CD4+、CD3+/CD8+、CD3-/CD19+、NK(CD3-/CD16+/CD56+)细胞的表达水平,结果示患儿CD4+、NK(CD3-/CD16+/CD56+)细胞百分率明显降低(P<0.05),CD8+、B(CD19+)细胞百分率明显升高(P<0.05)。结论小儿HLH病因复杂,临床表现多样,病死率较高,外周血淋巴细胞亚型的改变可能与其发病及病情严重程度密切相关。 Objective To analyze the etiology,clinical manifestations,diagnosis,therapy and prognosis of hemophagocytic lymphohistiocytosis(HLH)in pediatric patients.Methods Forty-two pediatric patients with HLH were retrospectively reviewed.Results In 26 boys and 16 girls,the clinical manifestations were featured with prolonged high fever and hepatosplenomegaly;in addition,the organs of the respiratory system,central nervous system,circulatory system and urinary tract were concurrently affected.Among the 42 cases,26 cases were infection-related,5 non-infection related,and 11 unknown.Treated as per HLH-94 or HLH-2004 scheme,19 cases were cured or improved,13 cases died and 10 cases failed to continue follow-up.The expression levels of CD3+/CD4+,CD3+/CD8+,CD3-/CD19+and NK cells(CD3-/CD16+/CD56+)in peripheral blood from these patients were determined by flow cytometry.The results showed significant decrease in CD4+,NK cells(CD3-/CD16+/CD56+,P0.05)and significant increase in CD8+,B(CD19+,P0.05)in these patients.Conclusion HLH is featured with complicated etiology,varying clinical manifestations and relatively high mortality.Changes in lymphocyte subsets in the peripheral blood of the patients are related to the onset and severity of HLH.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第5期616-619,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 噬血细胞淋巴组织细胞增生症 儿童 临床表现 病因 治疗 预后 hemophagocytic lymphohistiocytosis pedia clinical manifestation pathogenesis treatment prognosis
  • 相关文献

参考文献8

  • 1Henter J I, Horne A Aric6 M, et al. HLH 2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistio- cytosis[J]. Pediatr Blood Cancer,2007,48(2) :124-131.
  • 2Janka G. Familial and acquired hemophagocytic lymphohistio cytosis[J]. Eur J Pediatr,2007,21(5) :245-253.
  • 3Zur Stadt U,Beutel K,Kolberg S,et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11,and RAB27A[J]. Hum Mutat,2006,27(1)62-68.
  • 4Schneider E M, Lorenz I, Muller-Rosenberger M, et al. Flem- ophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts rele vant to killer celllnduced apoptosis[J]. Blood, 2002,100(8): 2891-2898.
  • 5江文,刘冬先,陈映玲,徐祖森,阎红.卡介菌多糖核酸对尖锐湿疣患者外周血T细胞亚群及其细胞因子表达的影响[J].华中科技大学学报(医学版),2006,35(3):407-410. 被引量:13
  • 6Loechelt B J, Egeler M, Filipovich A H, et al. Immunosup- pression:preliminary results of alternative maintenance thera- py for familial hemophagoeyticlymphohistocytosis(FHL)[J]. Med Pediatr Onco1,1994,22(5) :325 328.
  • 7Mouy R, Stephan J L, Pillet P, et aI. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in ju- venile arthritis : report of five cases [J ] J Pediatr, 1996, 129 (5) :750-754.
  • 8Horne A,Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocy tosis[J]. Br J Haematol,2005,129(5) :622- 630.

二级参考文献8

共引文献12

同被引文献27

  • 1Verbsky JW, Grossman WJ. Hemophagocytic lymphohis-tiocytosis: diagnosis, pathophysiology, treatment, and fu-ture perspectives [J]. Ann Med, 2006, 38(1): 20-31.
  • 2Filipevieh AH. Hemophagoeytie lymphohistioeytosis (HLH) and related disorders[M]. Hematology Am Soc Hematol Educ Program, 2009, 1(1): 127-131.
  • 3Mehta RS, Smith RE. Hemophagocytic lymphohistiocytosis (HLH): a review of literature. Med Oneol. 2013 Dee;30(4):740.
  • 4Guandalini M, Butler A, Mandelstam S. Spectrum of imaging appe- arances in Australian children with central nervous system hemophagoeytic lymphohistioeytosis.
  • 5Okamoto M, Yamaguchi H, Isobe Y,Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med. 2009;48(10):775-81.
  • 6Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis [J]. Ann Clin Lab Sci, 2012, 42(1):21-25.
  • 7Nielsen M J, Madsen M, M 11er HJ. The macrophage scavenger receptorCD163: endocytic properties of cytoplasmic tail variants. J Leukoc Bio,1 2006, 79: 1-9.
  • 8RavelliA, Magni-Manzoni S, PistorioA, et a,1 Prelmi inary diagno- stic guidelines formacrophage activation syndrome complicatingsystemic juvenile idiopathic arthritis. J Pediatr, 2005, 146: 598-604.
  • 9Filipovieh A H.Hemophagocytie lymphohistiocy - tosis(HLH) and related disorders[J].Hematologyam Soc Hematol Educ Program, 2009,1 : 17-131.
  • 10Tabata Y, Villanueva J, Lee SM, Rapid detection of intracellular SH2D1A protein in eytotoxic lymphoeytes from patients with X-linked lymphoproliferative disease and their family members.Blood. 2005 Apr 15;105(8):3066-71.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部